Subscribe to Here’s the Deal, our politics
newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
By John Yang, Winston Wilde, Andrew Corkery
A government advisory panel is meeting Thursday to determine if any restrictions are needed for the Johnson & Johnson COVID-19 vaccine because of rare but serious blood clots.
By Lauran Neergaard, Mike Stobbe, Associated Press
With a green light from federal health officials, several states resumed use of the one-shot Johnson & Johnson coronavirus vaccine on Saturday. Among the venues where it was being deployed: the Indianapolis Motor Speedway.
By David Crary, Associated Press
New research may offer at least a partial explanation for the phenomenon that has been seen with so-called adenovirus vaccines.
By Matthew Herper, STAT News
Wednesday's recommendation came as regulators both in the U.K. and the European Union emphasized that the benefits of receiving the vaccine continue to outweigh the risks for most people.
By Maria Cheng, Danica Kirka, Jill Lawless, Associated Press
By Vanessa Gera, Associated Press
Countries across Europe are resuming vaccinations with the AstraZeneca shot, as leaders seek to reassure their populations it is safe following brief suspensions that cast doubt on the vaccine.
Hillary Clinton's Hospitalization Sheds Light on Blood Clot Causes, Treatments…
Low doses of a generic blood-thinning drug can prevent the recurring, dangerous blood clots that afflict about 750,000 Americans annually, researchers announced Monday on the New England Journal of Medicine's Web site.
Support Provided By: